Jason N. Gorevic
Jason N. Gorevic's purchase track record
Jason N. Gorevic has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/10/2026 | KMPR | $130K | pending | pending | — |
| 8/7/2025 | KMPR | $98K | -27.4% | -32.9% | +7.2% |
| 8/3/2022 | KMPR | $129K | +6.2% | +33.5% | -0.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Teladoc Launches AI-Powered Remote Monitoring Tools. Teladoc Health has introduced new AI features that turn smartphone cameras into vital sign monitors and add ambient care tools to its Solo platform. These updates aim to strengthen the company's competitive position in digital health. While the stock has recently dipped more than the broader market, analysts maintain an average price target of $7.59, suggesting potential value relative to current levels.
Transaction History
| KMPR | ▲ Buy | Open Market | 5,000 | $130K | 8/10/2026 | View on chart |
| KMPR | ▲ Buy | Grant | 4,730 | $155K | 5/6/2026 | View on chart |
| KMPR | ▲ Buy | Open Market | 2,000 | $98K | 8/7/2025 | View on chart |
| KMPR | ▲ Buy | Grant | 2,435 | $150K | 5/7/2025 | View on chart |
| KMPR | ▲ Buy | Grant | 2,565 | $0 | 5/1/2024 | View on chart |
| TDOC | ▼ Sell | Open Market | 53,755 | $780K | 3/4/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 2,915 | — | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 5,782 | — | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 7,648 | — | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 21,130 | — | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 5,615 | — | 3/1/2024 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 62,004 | — | 3/1/2024 | View on chart |
| TDOC | ▼ Sell | Open Market | 2,877 | $54K | 12/4/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 5,615 | — | 12/1/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 2,864 | $66K | 9/5/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 5,614 | — | 9/1/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 10,000 | $300K | 7/27/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 2,802 | $68K | 6/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 5,614 | — | 6/1/2023 | View on chart |
| KMPR | ▲ Buy | Grant | 2,933 | $0 | 5/3/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 22,040 | $571K | 3/3/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 3,891 | — | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 7,648 | — | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 2,913 | — | 3/2/2023 | View on chart |
| TDOC | ▼ Sell | Open Market | 8,262 | $210K | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 9,104 | — | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 5,782 | — | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 15,476 | — | 3/2/2023 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 22,458 | — | 3/1/2023 | View on chart |
| KMPR | ▲ Buy | Open Market | 3,000 | $129K | 8/3/2022 | View on chart |
| KMPR | ▲ Buy | Grant | 2,525 | $0 | 5/4/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 16,778 | — | 3/4/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 21,812 | — | 3/4/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 15,478 | — | 3/2/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 5,782 | — | 3/2/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 3,893 | — | 3/2/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 9,103 | — | 3/2/2022 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 7,648 | — | 3/2/2022 | View on chart |
| KMPR | ▲ Buy | Grant | 614 | $0 | 2/2/2022 | View on chart |
| TDOC | ▼ Sell | Open Market | 5,237 | $787K | 11/2/2021 | View on chart |
| TDOC | ▼ Sell | Open Market | 4,763 | $721K | 11/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Kemper Q2 earnings reviewed alongside peers
Kemper Corporation's second-quarter results are being analyzed in comparison to other multi-line insurance companies. This review helps investors understand how KMPR performed relative to industry standards. The stock currently trades with a dividend yield of 2.91%, while analysts maintain an average price target of $36.33.
Kemper Q2 earnings reviewed alongside peers. Kemper Corporation's second-quarter results are being analyzed in comparison to other multi-line insurance companies. This review helps investors understand how KMPR performed relative to industry standards. The stock currently trades with a dividend yield of 2.91%, while analysts maintain an average price target of $36.33.